Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma.
about
Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori infection: a review of current diagnosis and managementRituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie.Limited role of bone marrow aspiration and biopsy in the initial staging work-up of gastric mucosa-associated lymphoid tissue lymphoma in Korea.Study of regulatory T-cells in patients with gastric malt lymphoma: influence on treatment response and outcome.Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series.Treatment of gastric mucosa-associated lymphoid tissue lymphoma: Helicobacter pylori eradication and beyond.Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists.Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years?Therapy of gastric mucosa-associated lymphoid tissue lymphoma.A phase II study of lenalidomide in patients with extranodal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT lymphoma).A phase II study of bortezomib in patients with MALT lymphomaClinical outcomes of radiation therapy for early-stage gastric mucosa-associated lymphoid tissue lymphomaMicroRNAs 142-3p, miR-155 and miR-203 Are Deregulated in Gastric MALT Lymphomas Compared to Chronic GastritisCorrelation of Endoscopic Findings of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma with Recurrence after Complete Remission.Treatment of gastric marginal zone lymphoma of MALT type.Extranodal and splenic small B-cell lymphoma.Gastrointestinal lymphoma: recent advances in diagnosis and treatment.Helicobacter pylori and gastric mucosa-associated lymphoid tissue lymphoma: recent progress in pathogenesis and managementClinical aspects of malt lymphomas.Role of follow-up endoscopic examination in treatment response assessment for patients with gastric diffuse large B cell lymphoma.A case of Helicobacter heilmannii-associated primary gastric mucosa-associated lymphoid tissue lymphoma achieving complete remission after eradication.Gastric mucosa-associated lymphoid tissue lymphomas and Helicobacter pylori infection: a Colombian perspectiveGastric MALT lymphoma with t(14;18)(q32;q21) involving IGH and BCL2 genes that responded to Helicobacter pylori eradication.First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma.Treatment of t(11;18)-positive gastric mucosa-associated lymphoid tissue lymphoma with rituximab and chlorambucil: clinical, histological, and molecular follow-up.Helicobacter pylori eradication in gastric diffuse large B cell lymphoma.Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type.Plasmacytic differentiation in MALT lymphomas following treatment with rituximab.Rituximab and chlorambucil versus rituximab alone in gastric mucosa-associated lymphoid tissue lymphoma according to t(11;18) status: a monocentric non-randomized observational study.Second complete remission of Helicobacter pylori negative gastric MALT lymphoma following antibiotic treatment.ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma.Gela histological scoring system for post-treatment biopsies of patients with gastric MALT lymphoma is feasible and reliable in routine practice.Prevalence and Implications of Bone Marrow Involvement in Patients with Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.Efficacy of ⁹⁰Yttrium-ibritumomab tiuxetan in relapsed/refractory extranodal marginal-zone lymphoma.Anti-Helicobacter pylori therapy in localized gastric mucosa-associated lymphoid tissue lymphoma: A prospective, nationwide, multicenter study in Japan.Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome
P2860
Q26741090-BD437D2E-88D1-41B9-B0DF-2B1889540DC5Q33403350-C6C528CD-F006-47AA-A3C5-2450EEBD6023Q34432169-3A7D6E5C-0A8C-4F7E-9B65-D1B2A14A25ABQ34532146-AC015229-A71C-4394-9866-B99FF2C23B10Q34653557-CDC1D057-4AD3-4239-9C92-9BCE0643F493Q36407449-FDDC5C6A-68AD-443F-A866-1137FDDC6726Q36584820-AB1A4D70-8BE9-4FE6-B675-D24478B73ABCQ36677699-D08AFA0B-BA53-46CD-9152-B7DA3AF4713EQ36847291-59673CEF-6624-4D7E-877F-8CA0B0E15DEDQ36862393-05D19D12-BFB8-4747-AF64-5DDABE43ED56Q37175630-BFB9B424-877C-4AC8-A547-31A01DC5601DQ37203563-4801BAE5-1FC0-4C82-B9A5-C832AF655C8AQ37607918-65860894-4216-45FB-891D-3A29AFD9D513Q37633931-045FDBAC-D857-4D63-92A8-98313777BCCDQ37768456-C7D02F5C-9D65-46A7-86A1-C2DF17CE2C60Q38071075-1798CBAC-B976-49FD-82F3-43F685922C81Q38103339-2E0E27FD-F741-4DC8-821B-F907B7F76C95Q38173350-4EE10AE8-353F-40C0-9304-3BD316F58F64Q38252813-C2AE74D3-7A57-48C3-B5F6-154AC2741AF2Q40675995-3FCB67B8-12C0-4A2C-99CF-6E9C7A6BF8FFQ40729644-E05AC1FB-CFA2-4E52-B320-2A2DE497407DQ41198857-CB7BB49D-986A-43EA-AC11-8B67220FBE91Q41609033-D5A492B3-84D3-4518-AB7D-0F813A93C2FAQ43045933-3D6935E6-FF2A-43E6-9322-F648215EAEEDQ43206352-1958EA37-8ADD-4E60-AC3E-EE83834A8F92Q43217279-56DB278E-2711-4BAA-B236-4A34340B2BD4Q43293479-4F22C6BC-A0B5-43E1-8AF0-8B709A98340DQ43635791-C39CA2FD-1C06-43C7-ABFF-AB08382A0B40Q43862285-525AD615-8145-4724-AFF8-7F932D07BF25Q43978041-9A336FC9-614D-4178-B519-D1FD7C8821ECQ45124918-3B4BEB3D-6849-47C6-AA3C-1FF8F05356EFQ45150144-D986E0DF-4627-45B0-B5F0-48B11ED27E9FQ50158367-9BE49F67-0194-40E8-BFDD-8F9567EA8997Q50972036-0B161768-601D-449B-9F47-D1FD8BC56AD6Q52674635-7C6D9636-8DF8-44FF-A4C1-482C308AC808Q57224018-E644A461-78BA-4923-A96E-1FDF3E2B42EA
P2860
Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Proposal for a new histologica ...... tion of gastric MALT lymphoma.
@en
Proposal for a new histologica ...... tion of gastric MALT lymphoma.
@nl
type
label
Proposal for a new histologica ...... tion of gastric MALT lymphoma.
@en
Proposal for a new histologica ...... tion of gastric MALT lymphoma.
@nl
prefLabel
Proposal for a new histologica ...... tion of gastric MALT lymphoma.
@en
Proposal for a new histologica ...... tion of gastric MALT lymphoma.
@nl
P2093
P2860
P356
P1433
P1476
Proposal for a new histologica ...... tion of gastric MALT lymphoma.
@en
P2093
Copie-Bergman C
Dordonne K
Lavergne-Slove A
Wotherspoon AC
de Mascarel A
P2860
P356
10.1136/GUT.52.11.1656
P407
P577
2003-11-01T00:00:00Z